In this Section |
247737 Differential Efficacy of Psychological and Pharmacological Interventions for PTSD: A Meta-Analytic ReviewMonday, October 31, 2011
Posttraumatic stress disorder (PTSD) is estimated to affect 8–9% of individuals in the population at some point in their lives. PTSD is associated with high rates of comorbidity. PTSD constitutes a major public health morbidity and mortality burden, highlighting the importance of prevention and intervention efforts. Treatment guidelines for PTSD include expert consensus reviews of the literature and quantitative reviews (i.e., meta-analyses). To a significant, but not overwhelming degree, recommendations are complementary across best-practice and meta-analytic formats. However, agreement across methodologies is not perfect. The current study reviews the extant literature on randomized controlled trials comparing the consensus best pharmacotherapy [Selective Serotonin Reuptake Inhibitors or Serotonin/Norepinephrine Reuptake Inhibitors (SSRIs, SNRIs)]with the consensus best psychological therapies (Trauma-focused Cognitive Behavior Therapy). The current meta-analysis follows the rigorous recommendations of meta-analytic methodological experts(e.g., PRISMA) in comparing the relative efficacy of pharmacological and psychological therapies for PTSD in the adult population. Subgroup and meta-regression analyses will examine relations such as baseline severity of PTSD symptoms, gender, comorbidity, depression diagnosis, baseline symptom scores, and attrition with psychological and pharmacologic treatments of PTSD. The comparative effectiveness of pharmacological and psychological interventions has substantial personal and public health implications.
Learning Areas:
Biostatistics, economicsClinical medicine applied in public health Other professions or practice related to public health Provision of health care to the public Learning Objectives: Keywords: Mental Illness, Treatment Efficacy
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I am qualified to present because I have training in experimental psychology, clinical psychology, psychiatric epidemiology, and mental health services research, and have directed research programs in behavioral epidemiology and clinical psychology in both government and academic settings, and currently teach, consult, and conduct research in research methodology and mental health as a faculty member at a large private university. I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
See more of: Mental health treatment models: Development, efficacy and implementation
See more of: Mental Health |